Record #28623
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer
Original paper date
Feb 5, 2019
Original DOI
Notes from Retraction Watch
see https://ascopubs.org/doi/10.1200/JCO.21.00280?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
Citation lifecycle
How this paper is being cited
Pre-retraction
19
Same day
0
Post-retraction
16
% post-retraction
45.7%
~8.3 citations/yr before retraction · ~3.0 citations/yr after
— citing papers
Who is still citing this work
Loading…